David P. Recker - Concepedia

Author

David P. Recker

Also Known As

D P Recker, D Recker, D. P. RECKER, D. P. Recker, D. Recker, DAVID P. RECKER, David P Recker, David P. Recker, David Recker, David P. Recker

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Aastrom Biosciences (United States)Rush University Medical Center University of Utah Health Care IQVIA (United States)University of California San Diego

About

David P. Recker is an author at Aastrom Biosciences (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.2K
2	Health Sciences	4	4	257
3	Engineering	1	1	271
4	Natural Sciences	1	1	45
5	Allergy	1	1	207

David P. Recker

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial Mats Brittberg, David P. Recker, John Ilgenfritz, The American Journal of Sports Medicine Tissue EngineeringEngineeringBone RepairProspective Randomized TrialSurgery	2018	271
A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics Trevor T. Hansel, Sergei A. Kharitonov, Louise Donnelly, The FASEB Journal AsthmaInflammatory Lung DiseaseLung InflammationNitric OxideImmunology	2003	207
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial Amit N. Patel, Timothy D. Henry, Arshed A. Quyyumi, The Lancet ThrombosisHeart FailureTransplantationCardiovascular DiseaseDouble-blind Trial	2016	168
Valdecoxib, a COX-2???Specific Inhibitor, Is an Efficacious, Opioid-Sparing Analgesic in Patients Undergoing Hip Arthroplasty Frédéric Camu, Tessa Beecher, David P. Recker, American Journal of Therapeutics	2002	141
A Single Preoperative Oral Dose of Valdecoxib, a New Cyclooxygenase-2 Specific Inhibitor, Relieves Post-Oral Surgery or Bunionectomy Pain Paul J. Desjardins, Vincent Shu, David P. Recker, Anesthesiology	2002	125
The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery Stephen E. Daniels, Paul J. Desjardins, Sheela Talwalker, The Journal of the American Dental Association Health SciencesOral SurgeryPain MedicineMedicinePostoperative Pain Management	2002	120
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen William S. Makarowski, William W. Zhao, Terry Bevirt, Osteoarthritis and Cartilage Placebo-controlled ComparisonPharmacologyChronic Musculoskeletal ConditionOsteoarthritisNon-operative Management	2002	108
Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. Alan Kivitz, Glenn M. Eisen, William W. Zhao, PubMed	2002	106
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis David Sikes, Naurang M. Agrawal, William W. Zhao, European Journal of Gastroenterology & Hepatology	2002	105
Lack of an Effect of a Novel β3-Adrenoceptor Agonist, TAK-677, on Energy Metabolism in Obese Individuals: A Double-Blind, Placebo-Controlled Randomized Study Leanne M. Redman, Lilian de Jonge, Xiaobing Fang, The Journal of Clinical Endocrinology & Metabolism	2006	90

Page 1